版本:
中国

BRIEF-Cannimed Therapeutics' Q2 loss per share $0.08

June 12 Cannimed Therapeutics Inc

* Cannimed Therapeutics Inc reports financial results for Q2 2017

* Qtrly revenue increased to $3.7 million from $2.2 million for comparable period in previous fiscal year

* Qtrly loss per share $0.08 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐